InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

- Current share price for GSS : $0.084

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$19 Update on Commercial Terms for the Proposed Merger with MAP 21 Oct 2026 9:18AM $0.084 $0.084 fallen by 0%
$19 Response to Media Speculation & BCAL letter to GSS 16 Oct 2026 8:25PM $0.080 $0.084 risen by 5%
$19 2026 Notice of Annual General Meeting 16 Oct 2026 9:09AM $0.080 $0.084 risen by 5%
$19 Quarterly Activities/Appendix 4C Cash Flow Report 8 Oct 2026 12:36PM $0.077 $0.084 risen by 9.09%
$19 Becoming a substantial holder 28 Sep 2026 2:55PM $0.078 $0.084 risen by 7.69%
$19 Notice of Extraordinary General Meeting 23 Sep 2026 2:03PM $0.075 $0.084 risen by 12%
$19 GSS Investor Presentation - Proposed Merger with MAP 22 Sep 2026 9:46AM $0.074 $0.084 risen by 13.51%
$19 GSS and MAP agree to Commercial Terms for Merger 22 Sep 2026 9:25AM $0.074 $0.084 risen by 13.51%
$19 Receipt of Section 249D Notice from BCAL Diagnostics 17 Sep 2026 9:49AM $0.073 $0.084 risen by 15.07%
$19 Date of AGM and Closing Date for Director Nominations 14 Sep 2026 9:49AM $0.080 $0.084 risen by 5%
$19 BDX Holdings of GSS Shares and receipt of Section 249D 3 Sep 2026 9:37AM $0.090 $0.084 fallen by 6.67%
$19 Final Director's Interest Notice 1 Sep 2026 12:12PM $0.090 $0.084 fallen by 6.67%
$19 Board Changes 31 Aug 2026 8:39AM $0.080 $0.084 risen by 5%
$19 Ceasing to be a substantial holder 27 Aug 2026 4:24PM $0.087 $0.084 fallen by 3.45%
$19 Genetic Signatures and Microba in Merger Discussions 26 Aug 2026 9:30AM $0.080 $0.084 risen by 5%
$19 Change in Substantial Shareholder Notice from BDX 26 Aug 2026 8:35AM $0.080 $0.084 risen by 5%
$19 Change in substantial holding 25 Aug 2026 2:12PM $0.076 $0.084 risen by 10.53%
$19 FY26 Appendix 4G and Corporate Governance Statement 25 Aug 2026 9:29AM $0.073 $0.084 risen by 15.07%
$19 FY26 Market Update 25 Aug 2026 9:25AM $0.073 $0.084 risen by 15.07%
$19 FY26 Results Release 25 Aug 2026 9:15AM $0.073 $0.084 risen by 15.07%
$19 FY26 Appendix 4E and Annual Report 25 Aug 2026 9:09AM $0.073 $0.084 risen by 15.07%
$19 FY 26 Annual Results and Investor Webinar Notification 24 Aug 2026 10:16AM $0.067 $0.084 risen by 25.37%
$19 Commercial Testing Commences at Hvidovre Hospital in Denmark 21 Aug 2026 9:26AM $0.063 $0.084 risen by 33.33%
$19 Quarterly Activities/Appendix 4C Cash Flow Report 23 Jul 2026 2:11PM $0.059 $0.084 risen by 42.37%
$19 Becoming a substantial holder from BDX 2 Jul 2026 5:13PM $0.065 $0.084 risen by 29.23%

1 - 25 of 527 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.